UPDATE : Tuesday, July 7, 2020
Mundipharma to commercialize Samsung Bioepis’ biosimilar in Hong Kong, Taiwan
Mundipharma said that it has entered into a partnership with Samsung Bioepi...
by Lee Han-soo  |  2020-01-13 16:23
BioMarin seeks license for gene therapy to treat hemophilia
The world might be one step closer to the eradication of hemophilia.BioMari...
by Kim Yun-mi  |  2020-01-06 16:44
[New Year Special] Biotech rookies may shake up market cap rankings
Korean biotech companies, which drove up the buying spree on the Kosdaq mar...
by Jeong Sae-im  |  2020-01-02 14:31
Humedix wins patent on new anti-aging material
Humedix said it has won a local patent on a new substance called “nicotinam...
by Jeong Sae-im  |  2019-12-26 14:31
Vaxcell-Bio Therapeutics passes tech review for Kosdaq debut
Vaxcell-Bio Therapeutics, an immunotherapy developer, said it has passed th...
by Jeong Sae-im  |  2019-12-23 15:42
Samsung Bioepis’ Ontruzant 1st biosimilar to win WHO's PQ certification
Samsung Bioepis announced that Ontruzant, a trastuzumab biosimilar (Origina...
by Lee Han-soo  |  2019-12-20 16:29
Kolon appeals Invossa’s safety in pleading at court
Kolon Life Science is working flat out to prove the safety of Invossa-K, th...
by Jeong Sae-im  |  2019-12-20 14:57
4 firms to offer up to 56 direct-to-consumer genetic testing services
The government said it has allowed four companies, including Theragen Etex ...
by Jeong Sae-im  |  2019-12-19 16:40
Psomagen-Macrogen consortium acquires uBiome's patents, data
Psomagen and Macrogen said that they have acquired uBiome's 246 microbi...
by Lee Han-soo  |  2019-12-18 16:56
Venture capital investment in biomedical sector to hit record this year
Despite disappointing clinical trial failures by major biotech firms, ventu...
by Jeong Sae-im  |  2019-12-17 14:20
Celltrion secures 11 generic drugs to advance to US market
Celltrion said it is speeding up efforts to enter into the U.S. market afte...
by Lee Han-soo  |  2019-12-16 17:02
Helixmith to clarify why gene therapy study had data error
Helixmith said it would announce next month the cause of the data error in ...
by Jeong Sae-im  |  2019-12-13 15:13
Yuhan to start phase-3 trial on lung cancer drug Lazertinib
Yuhan Corp. said it would start a phase-3 global study to evaluate the effi...
by Jeong Sae-im  |  2019-12-12 15:04
Aprogen, 1st Korean biotech firm to win unicorn status
Aprogen has joined the list of unicorn companies, as the first Korean biote...
by Jeong Sae-im  |  2019-12-11 13:10
Samsung Bioepis to start P3 trial for Ontruzant in China
Samsung Bioepis said that China’s National Medical Products Administration ...
by Lee Han-soo  |  2019-12-10 14:16
Samsung execs get jail term for destroying evidence
A Seoul court gave jail terms to Samsung executives for destroying evidence...
by Jeong Sae-im  |  2019-12-10 11:43
Celltrion unveils long-term P3 trial results for Truxima in US
Celltrion said that it has presented the long-term follow-up results of its...
by Lee Han-soo  |  2019-12-09 10:36
Celltrion 1st Korean biopharmaceutical firm to achieve $1-billion exports
Celltrion Healthcare said that it has become the first local biopharmaceuti...
by Lee Han-soo  |  2019-12-05 15:04
Alteogen inks licensing-out deal for SC injection formulation technology
Alteogen, a biotech firm, said it has successfully concluded a deal to make...
by Jeong Sae-im  |  2019-12-02 15:25
Kolon Life Science’s research head arrested for false Invossa data
A Seoul court issued an arrest warrant for an executive at Kolon Life Scien...
by Jeong Sae-im  |  2019-11-28 11:18
Back to Top